Your browser doesn't support javascript.
loading
ABL1 kinase as a tumor suppressor in AML1-ETO and NUP98-PMX1 leukemias.
Golovine, Konstantin; Abalakov, Gleb; Lian, Zhaorui; Chatla, Srinivas; Karami, Adam; Chitrala, Kumaraswamy Naidu; Madzo, Jozef; Nieborowska-Skorska, Margaret; Huang, Jian; Skorski, Tomasz.
Afiliação
  • Golovine K; Fels Cancer Institute for Personalized Medicine, Temple University Lewis Katz School of Medicine, Philadelphia, PA, USA.
  • Abalakov G; Fels Cancer Institute for Personalized Medicine, Temple University Lewis Katz School of Medicine, Philadelphia, PA, USA.
  • Lian Z; Coriell Institute for Medical Research, Camden, NJ, USA.
  • Chatla S; Fels Cancer Institute for Personalized Medicine, Temple University Lewis Katz School of Medicine, Philadelphia, PA, USA.
  • Karami A; Fels Cancer Institute for Personalized Medicine, Temple University Lewis Katz School of Medicine, Philadelphia, PA, USA.
  • Chitrala KN; Fels Cancer Institute for Personalized Medicine, Temple University Lewis Katz School of Medicine, Philadelphia, PA, USA.
  • Madzo J; Coriell Institute for Medical Research, Camden, NJ, USA.
  • Nieborowska-Skorska M; Fels Cancer Institute for Personalized Medicine, Temple University Lewis Katz School of Medicine, Philadelphia, PA, USA.
  • Huang J; Coriell Institute for Medical Research, Camden, NJ, USA. jhuang@coriell.org.
  • Skorski T; Fels Cancer Institute for Personalized Medicine, Temple University Lewis Katz School of Medicine, Philadelphia, PA, USA. tskorski@temple.edu.
Blood Cancer J ; 13(1): 42, 2023 03 23.
Article em En | MEDLINE | ID: mdl-36959186

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia / Fosfatidilinositol 3-Quinases Limite: Animals / Humans Idioma: En Revista: Blood Cancer J Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia / Fosfatidilinositol 3-Quinases Limite: Animals / Humans Idioma: En Revista: Blood Cancer J Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos